SCHEMBL16124349

SCHEMBL16124349

CCCCc1cc(O)c2c(c1)OC(C)(C)C1=C2CC(C)CC1

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 13/20 0.94
▸ CNR1 P21554 11/20 0.94
▸ MEN1 O00255 1/20 0.67
▸ GAA P10253 1/20 0.67
▸ KMT2A Q03164 1/20 0.67
▸ TRPV1 Q8NER1 3/20 0.47
▸ TRPA1 O75762 2/20 0.47
▸ TRPV3 Q8NET8 2/20 0.47
▸ TRPV4 Q9HBA0 2/20 0.47
▸ TRPV2 Q9Y5S1 2/20 0.47
▸ CYP1A1 P04798 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2A6 P11509 1/20 0.47
▸ CYP2B6 P20813 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ HTR2A P28223 1/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ OPRM1 P35372 1/20 0.47
▸ CYP2J2 P51589 1/20 0.47
▸ CYP1B1 Q16678 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5090381 0.97 CNR2 (1.00) CNR2CNR1MEN1GAAKMT2A
SCHEMBL31103617 0.97 CNR2 (1.00) CNR2CNR1MEN1GAAKMT2A
SCHEMBL4537590 0.97 CNR2 (1.00) CNR2CNR1MEN1GAAKMT2A
SCHEMBL1114914 0.96 CNR2 (0.98) CNR2CNR1MEN1GAAKMT2A
SCHEMBL22783274 0.89 CNR2 (0.78) CNR2CNR1MEN1GAAKMT2A
SCHEMBL11741078 0.88 CNR2 (0.76) CNR2CNR1MEN1GAAKMT2A
SCHEMBL11757291 0.87 CNR2 (0.82) CNR2CNR1MEN1GAAKMT2A
SCHEMBL31545082 0.86 CNR2 (0.81) CNR2CNR1MEN1GAAKMT2A
SCHEMBL25981698 0.86 CNR2 (0.80) CNR2CNR1MEN1GAAKMT2A
SCHEMBL11665838 0.83 CNR2 (0.69) CNR2CNR1MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220152138-A1 METHODS FOR PRODUCTION OF LOW COST TERPENOIDS, INCLUDING CANNABINOIDS, AND VARIETIES ADAPTED FOR LARGE-SCALE PLANTING AND DENSITY OPTIMIZATION INCLUDING CANNABINOID PRESERVATION NEW WEST GENETICS, INC. 2022-05-19 — — US disclosed
US-9095554-B2 Breeding, production, processing and use of specialty cannabis Biotech Institute LLC (US) 2015-08-04 — — US disclosed
US-9095554-B2 Breeding, production, processing and use of specialty cannabis Biotech Institute LLC (US) 2015-08-04 — — US disclosed
US-20140287068-A1 BREEDING, PRODUCTION, PROCESSING AND USE OF SPECIALTY CANNABIS Biotech Institute LLC (US) 2014-09-25 — — US disclosed
US-20140287068-A1 BREEDING, PRODUCTION, PROCESSING AND USE OF SPECIALTY CANNABIS Biotech Institute LLC (US) 2014-09-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140287068-A1 BREEDING, PRODUCTION, PROCESSING AND USE OF SPECIALTY CANNABIS CNR1, CNR2, SCD CNR2 2/4885CNR1 1/4885MEN1 4267/4885
US-20220152138-A1 METHODS FOR PRODUCTION OF LOW COST TERPENOIDS, INCLUDING CANNABINOIDS, AND VARIETIES ADAPTED FOR LARGE-SCALE PLANTING AND DENSITY OPTIMIZATION INCLUDING CANNABINOID PRESERVATION CNR2, CNR1, DGAT2 CNR2 1/4885CNR1 2/4885MEN1 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback